Due to consistent advancements in the cardiovascular medicine field, stenting of the arteries has emerged as one of the most common and popular cardiovascular treatment. As stenting continues to gain popularity across the world, the demand for vascular stents continues to gain considerable traction. The alarming rise in the number of patients suffering from cardiovascular diseases has compelled the medical sector to focus on new treatments and medical concepts to improve the recovery rate of existing treatments. At present, existing technologies, particularly related to drug-eluting stents have witnessed rapid developments.
In addition, due to added research, these technologies continue to demonstrate high levels of efficacy and low rate of treatment failure due to which, applications of vascular stents continue to expand at a promising rate– a leading factor that is expected to drive the vascular stents market during the forecast period. Over the past few decades, participants operating in the vascular stents market are increasingly focusing on minimizing various complications involved with vascular stent implantations such as local chronic inflammation, in-stent restenosis, re-occlusion rates, and late thrombosis.
Considerable emphasis is being laid on various parameters of vascular stent development to facilitate long-term stability and assess various failure mechanisms. Currently, vascular stent technologies primarily focus on addressing the restenosis rate of high-risk patients in both, bare-metal stents as well as drug-eluting stents. At the back of these factors, along with growing demand for minimally invasive therapies, the global vascular stents market is expected to reach ~US$ 12 Bn by the end of 2027.
The first-generation of vascular stents that were predominantly fabricated from cobalt-chromium, platinum-iridium, and stainless steel put forward an array of problems that led to tissue hyperplasia. Shortcomings and several other minor drawbacks of the first-generation of vascular stents accelerated the production of drug-eluting stents, biodegradable stents, and coated stents. Several vascular stent manufacturers are increasingly prioritizing the optimization of the physical-chemical, biological, and mechanical stent properties to attain the desired characteristics of various stents.
Some of the major developments and fabrication technologies in the vascular stents market are likely to focus on various properties, including expandability ration, compatibility with a balloon catheter, magnetic resonance imaging, flexibility, and thromboresistivity. The high mortality rate associated with cardiovascular diseases around the world coupled with innovative stent technology concepts has prompted clinicians and researchers to focus on the development of new techniques, materials, and solutions to enhance the clinical outcome of the currently deployed vascular stents.
As cardiovascular diseases continue to be among the leading causes of death around the world, consistent efforts are being made to address this looming medical problem. The existing anti-atherosclerotic and pharmacological modalities still fall short in controlling the disease due to which, enhancements in clinical interventions is the need of the hour. As a result of research, experts in the healthcare sector are of the opinion that bio-sensing devices offer immense promise in addressing in-stent restenosis. Moreover, due to the progress in nanofabrication, researchers continue to explore the various ways in which biosensors can be integrated into vascular stents to address the shortcomings of the existing stent modalities.
The “Internet of Things” is expected to play a major role in the development of the next-generation of vascular stents. One of the recent developments across the vascular stents market that have gained considerable spotlight is the onset of bioresorbable stents. Analysts at Transparency Market Research predict that the adoption of bioresorbable stents is likely to witness considerable growth over the course of the forecast period due to the limitations of metal stents.
As the ongoing COVID-19 pandemic continues to derail the global economic growth, the medical sector continues to witness considerable movement. While the demand for personal protective equipment and other medical medicines and devices required for the treatment of the novel COVID-19 coronavirus is expected to skyrocket, the demand for vascular stents is likely to fluctuate due to lack of information regarding the potential impact of the virus on heart patients.
Several studies have suggested that individuals suffering from cardiovascular diseases are at a higher risk of contracting COVID-19 infection. While government regulations and guidelines continue to prioritize trade of COVID-19 medication and devices, the demand for vascular stents is likely to remain steady. Although it is hard to predict the demand pattern due to several external factors, the vascular stents market is expected to witness a lower growth rate compared with that of 2019.
Analysts’ Viewpoint
The global vascular stents market is expected to grow at a moderate CAGR of ~5% during the forecast period. The considerable rise in the number of patients suffering from cardiovascular diseases, research & development activities, focus on improving the efficacy of existing stent technologies, and focus on the production of cutting-edge stents integrated with biosensors are some of the leading factors that will provide a boost to the growth of the vascular stents market during the forecast period. Market players should focus on research and development of new vascular stents that offer improved performance in comparison with first-generation stents fabricated from stainless steel and other metals. Biodegradable stents are likely to gain popularity in the upcoming years and could potentially replace vascular stents fabricated from metals.
Vascular Stents Market - Segmentation
|
Type |
Coronary Artery Stents
Peripheral Vascular Stents
Neurovascular Stents
|
|
Delivery Method |
Balloon Expandable Stents Self-expanding Stents |
|
Material |
Cobalt-Chromium Stent Platinum-Chromium Stent Nitinol Stent Stainless Steel Stent Bioresorbable Polymer Stent |
|
End User |
Hospitals Cardiac Centers Ambulatory Surgical Centers |
|
Region |
North America Europe Asia Pacific Latin America Middle East & Africa |
The global vascular stents market was worth US$ 7.6 Bn and is projected to reach a value of US$ 12 Bn by the end of 2027
Vascular stents market is anticipated to grow at a CAGR of 5% during the forecast period
North America accounted for a major share of the global vascular stents market
Vascular stents market is driven by rise in prevalence of cardiovascular diseases and increase in demand for minimally invasive surgeries are anticipated to drive the global market
Key players in the global vascular stents market include Abbott Vascular (Abbott Laboratories), Cordis Corporation (A Cardinal Health Company), Medtronic, Boston Scientific Corporation, BIOTRONIK AG, Lifetech Scientific, C. R. Bard, Inc. (Becton, Dickinson and Company), Biosensors International Group, Ltd., Cook Medical, and W. L. Gore & Associates, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Vascular Stents Market
4. Market Overview
4.1. Introduction
4.1.1. Vascular Stents Market Introduction
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Vascular Stents Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Mergers & Acquisitions
5.2. Technological Advancements
5.3. Disease Prevalence & Incidence Rate globally with key countries
5.4. Vascular Stents Product Mapping
6. Global Vascular Stents Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017–2027
6.3.1. Coronary Artery Stents
6.3.1.1. Bare Metal Stents
6.3.1.2. Bioresorbable Stents
6.3.1.3. Covered Stents
6.3.1.4. Drug Eluting Stents
6.3.2. Peripheral Vascular Stents
6.3.2.1. Fem-pop Artery Stents
6.3.2.2. Iliac Artery Stents
6.3.2.3. Infrapop Artery Stents
6.3.3. Neurovascular Stents
6.4. Market Attractiveness, by Type
7. Global Vascular Stents Market Analysis and Forecast, by Delivery Method
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Delivery Method, 2017–2027
7.3.1. Balloon Expandable Stents
7.3.2. Self-expanding Stents
7.4. Market Attractiveness, by Delivery Method
8. Global Vascular Stents Market Analysis and Forecast, by Material
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Material, 2017–2027
8.3.1. Cobalt-Chromium Stent
8.3.2. Platinum-Chromium Stent
8.3.3. Nitinol Stent
8.3.4. Stainless Steel Stent
8.3.5. Bioresorbable Polymer Stent
8.4. Market Attractiveness, by Material
9. Global Vascular Stents Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2017–2027
9.3.1. Hospitals
9.3.2. Cardiac Centers
9.3.3. Ambulatory Surgical Centers
9.4. Market Attractiveness, by End-user
10. Global Vascular Stents Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Vascular Stents Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017–2027
11.2.1. Coronary Artery Stents
11.2.1.1. Bare Metal Stents
11.2.1.2. Bioresorbable Stents
11.2.1.3. Covered Stents
11.2.1.4. Drug Eluting Stents
11.2.2. Peripheral Vascular Stents
11.2.2.1. Fem-pop Artery Stents
11.2.2.2. Iliac Artery Stents
11.2.2.3. Infrapop Artery Stents
11.2.3. Neurovascular Stents
11.3. Market Value Forecast, by Delivery Method, 2017–2027
11.3.1. Balloon Expandable Stents
11.3.2. Self-expanding Stents
11.4. Market Value Forecast, by Material, 2017–2027
11.4.1. Cobalt-Chromium Stent
11.4.2. Platinum-Chromium Stent
11.4.3. Nitinol Stent
11.4.4. Stainless Steel Stent
11.4.5. Bioresorbable Polymer Stent
11.5. Market Value Forecast, by End-user, 2017–2027
11.5.1. Hospitals
11.5.2. Cardiac Centers
11.5.3. Ambulatory Surgical Centers
11.6. Market Value Forecast, by Country, 2017–2027
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Type
11.7.2. By Delivery Method
11.7.3. By Material
11.7.4. By End-user
11.7.5. By Country
12. Europe Vascular Stents Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017–2027
12.2.1. Coronary Artery Stents
12.2.1.1. Bare Metal Stents
12.2.1.2. Bioresorbable Stents
12.2.1.3. Covered Stents
12.2.1.4. Drug Eluting Stents
12.2.2. Peripheral Vascular Stents
12.2.2.1. Fem-pop Artery Stents
12.2.2.2. Iliac Artery Stents
12.2.2.3. Infrapop Artery Stents
12.2.3. Neurovascular Stents
12.3. Market Value Forecast, by Delivery Method, 2017–2027
12.3.1. Balloon Expandable Stents
12.3.2. Self-expanding Stents
12.4. Market Value Forecast, by Material, 2017–2027
12.4.1. Cobalt-Chromium Stent
12.4.2. Platinum-Chromium Stent
12.4.3. Nitinol Stent
12.4.4. Stainless Steel Stent
12.4.5. Bioresorbable Polymer Stent
12.5. Market Value Forecast, by End-user, 2017–2027
12.5.1. Hospitals
12.5.2. Cardiac Centers
12.5.3. Ambulatory Surgical Centers
12.6. Market Value Forecast, by Country/Sub-region, 2017–2027
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Type
12.7.2. By Delivery Method
12.7.3. By Material
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Vascular Stents Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017–2027
13.2.1. Coronary Artery Stents
13.2.1.1. Bare Metal Stents
13.2.1.2. Bioresorbable Stents
13.2.1.3. Covered Stents
13.2.1.4. Drug Eluting Stents
13.2.2. Peripheral Vascular Stents
13.2.2.1. Fem-pop Artery Stents
13.2.2.2. Iliac Artery Stents
13.2.2.3. Infrapop Artery Stents
13.2.3. Neurovascular Stents
13.3. Market Value Forecast, by Delivery Method, 2017–2027
13.3.1. Balloon Expandable Stents
13.3.2. Self-expanding Stents
13.4. Market Value Forecast, by Material, 2017–2027
13.4.1. Cobalt-Chromium Stent
13.4.2. Platinum-Chromium Stent
13.4.3. Nitinol Stent
13.4.4. Stainless Steel Stent
13.4.5. Bioresorbable Polymer Stent
13.5. Market Value Forecast, by End-user, 2017–2027
13.5.1. Hospitals
13.5.2. Cardiac Centers
13.5.3. Ambulatory Surgical Centers
13.6. Market Value Forecast, by Country/Sub-region, 2017–2027
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Type
13.7.2. By Delivery Method
13.7.3. By Material
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Vascular Stents Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017–2027
14.2.1. Coronary Artery Stents
14.2.1.1. Bare Metal Stents
14.2.1.2. Bioresorbable Stents
14.2.1.3. Covered Stents
14.2.1.4. Drug Eluting Stents
14.2.2. Peripheral Vascular Stents
14.2.2.1. Fem-pop Artery Stents
14.2.2.2. Iliac Artery Stents
14.2.2.3. Infrapop Artery Stents
14.2.3. Neurovascular Stents
14.3. Market Value Forecast, by Delivery Method, 2017–2027
14.3.1. Balloon Expandable Stents
14.3.2. Self-expanding Stents
14.4. Market Value Forecast, by Material, 2017–2027
14.4.1. Cobalt-Chromium Stent
14.4.2. Platinum-Chromium Stent
14.4.3. Nitinol Stent
14.4.4. Stainless Steel Stent
14.4.5. Bioresorbable Polymer Stent
14.5. Market Value Forecast, by End-user, 2017–2027
14.5.1. Hospitals
14.5.2. Cardiac Centers
14.5.3. Ambulatory Surgical Centers
14.6. Market Value Forecast, by Country/Sub-region, 2017–2027
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Type
14.7.2. By Delivery Method
14.7.3. By Material
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Vascular Stents Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Type, 2017–2027
15.2.1. Coronary Artery Stents
15.2.1.1. Bare Metal Stents
15.2.1.2. Bioresorbable Stents
15.2.1.3. Covered Stents
15.2.1.4. Drug Eluting Stents
15.2.2. Peripheral Vascular Stents
15.2.2.1. Fem-pop Artery Stents
15.2.2.2. Iliac Artery Stents
15.2.2.3. Infrapop Artery Stents
15.2.3. Neurovascular Stents
15.3. Market Value Forecast, by Delivery Method, 2017–2027
15.3.1. Balloon Expandable Stents
15.3.2. Self-expanding Stents
15.4. Market Value Forecast, by Material, 2017–2027
15.4.1. Cobalt-Chromium Stent
15.4.2. Platinum-Chromium Stent
15.4.3. Nitinol Stent
15.4.4. Stainless Steel Stent
15.4.5. Bioresorbable Polymer Stent
15.5. Market Value Forecast, by End-user, 2017–2027
15.5.1. Hospitals
15.5.2. Cardiac Centers
15.5.3. Ambulatory Surgical Centers
15.6. Market Value Forecast, by Country/Sub-region, 2017–2027
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Type
15.7.2. By Delivery Method
15.7.3. By Material
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (by Tier and Size of companies)
16.2. Market Share Analysis by Company (2018)
16.3. Company Profiles
16.3.1. Abbott Vascular (Abbott Laboratories)
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Growth Strategies
16.3.1.3. SWOT Analysis
16.3.2. Cordis Corporation (A Cardinal Health Company)
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Growth Strategies
16.3.2.3. SWOT Analysis
16.3.3. Medtronic
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Growth Strategies
16.3.3.3. SWOT Analysis
16.3.4. Boston Scientific Corporation
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Growth Strategies
16.3.4.3. SWOT Analysis
16.3.5. BIOTRONIK AG
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Growth Strategies
16.3.5.3. SWOT Analysis
16.3.6. Lifetech Scientific
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Growth Strategies
16.3.6.3. SWOT Analysis
16.3.7. C. R. Bard, Inc. (Becton, Dickinson and Company)
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Growth Strategies
16.3.7.3. SWOT Analysis
16.3.8. Biosensors International Group, Ltd.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Growth Strategies
16.3.8.3. SWOT Analysis
16.3.9. Cook Medical
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Growth Strategies
16.3.9.3. SWOT Analysis
16.3.10. W. L. Gore & Associates, Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Growth Strategies
16.3.10.3. SWOT Analysis
List of Tables
Table 01: Global Vascular Stents Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 02: Global Vascular Stents Market Value (US$ Mn) Forecast, by Coronary Artery Stents, 2017–2027
Table 03: Global Vascular Stents Market Value (US$ Mn) Forecast, by Peripheral Vascular Stents, 2017–2027
Table 04: Global Vascular Stents Market Value (US$ Mn) Forecast, by Delivery Method, 2017–2027
Table 05: Global Vascular Stents Market Value (US$ Mn) Forecast, by Material, 2017–2027
Table 06: Global Vascular Stents Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 07: Global Vascular Stents Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 08: North America Vascular Stents Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 09: North America Vascular Stents Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 10: North America Vascular Stents Market Value (US$ Mn) Forecast, by Coronary Artery Stents, 2017–2027
Table 11: North America Vascular Stents Market Value (US$ Mn) Forecast, by Peripheral Vascular Stents, 2017–2027
Table 12: North America Vascular Stents Market Value (US$ Mn) Forecast, by Delivery Method, 2017–2027
Table 13: Global Vascular Stents Market Value (US$ Mn) Forecast, by Material, 2017–2027
Table 14: North America Vascular Stents Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 15: Europe Vascular Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 16: Europe Vascular Stents Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 17: Europe Vascular Stents Market Value (US$ Mn) Forecast, by Coronary Artery Stents, 2017–2027
Table 18: Europe Vascular Stents Market Value (US$ Mn) Forecast, by Peripheral Vascular Stents, 2017–2027
Table 19: Europe Vascular Stents Market Value (US$ Mn) Forecast, by Delivery Method, 2017–2027
Table 20: Global Vascular Stents Market Value (US$ Mn) Forecast, by Material, 2017–2027
Table 21: Europe Vascular Stents Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 22: Asia Pacific Vascular Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 23: Asia Pacific Vascular Stents Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 24: Asia Pacific Vascular Stents Market Value (US$ Mn) Forecast, by Coronary Artery Stents, 2017–2027
Table 25: Asia Pacific Vascular Stents Market Value (US$ Mn) Forecast, by Peripheral Vascular Stents, 2017–2027
Table 26: Asia Pacific Vascular Stents Market Value (US$ Mn) Forecast, by Delivery Method, 2017–2027
Table 27: Asia Pacific Vascular Stents Market Value (US$ Mn) Forecast, by Material, 2017–2027
Table 28: Asia Pacific Vascular Stents Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 29: Latin America Vascular Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 30: Latin America Vascular Stents Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 31: Latin America Vascular Stents Market Value (US$ Mn) Forecast, by Coronary Artery Stents, 2017–2027
Table 32: Latin America Vascular Stents Market Value (US$ Mn) Forecast, by Peripheral Vascular Stents, 2017–2027
Table 33: Latin America Vascular Stents Market Value (US$ Mn) Forecast, by Delivery Method, 2017–2027
Table 34: Latin America Vascular Stents Market Value (US$ Mn) Forecast, by Material, 2017–2027
Table 35: Latin America Vascular Stents Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 36: Middle East & Africa Vascular Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 37: Middle East & Africa Vascular Stents Market Value (US$ Mn) Forecast, by Type, 2017–2027
Table 38: Middle East & Africa Vascular Stents Market Value (US$ Mn) Forecast, by Coronary Artery Stents, 2017–2027
Table 39: Middle East & Africa Vascular Stents Market Value (US$ Mn) Forecast, by Peripheral Vascular Stents, 2017–2027
Table 40: Middle East & Africa Vascular Stents Market Value (US$ Mn) Forecast, by Delivery Method, 2017–2027
Table 41: Middle East & Africa Vascular Stents Market Value (US$ Mn) Forecast, by Material, 2017–2027
Table 42: Middle East & Africa Vascular Stents Market Value (US$ Mn) Forecast, by End-user, 2017–2027
List of Figures
Figure 01: Global Vascular Stents Market Value (US$ Mn) Forecast, 2017–2027
Figure 02: Global Vascular Stents Market Value Share, by Type, 2018
Figure 03: Global Vascular Stents Market Value Share, by Delivery Method, 2018
Figure 04: Global Vascular Stents Market Value Share, by Material, 2018
Figure 05: Global Vascular Stents Market Value Share, by End-user, 2018
Figure 06: Global Vascular Stents Market Value Share, by region, 2018
Figure 07: Global Vascular Stents Market Value Share Analysis, by Type, 2018 and 2027
Figure 08: Global Vascular Stents Market Attractiveness Analysis, by Type, 2019–2027
Figure 09: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Coronary Artery Stents , 2017–2027
Figure 10: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Peripheral Vascular Stents, 2017–2027
Figure 11: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Neurovascular Stents, 2017–2027
Figure 12: Global Vascular Stents Market Value Share Analysis, by Delivery Method, 2018 and 2027
Figure 13: Global Vascular Stents Market Attractiveness Analysis, by Delivery Method, 2019–2027
Figure 14: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Balloon Expandable Stents, 2017–2027
Figure 15: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Self-expanding Stents, 2017–2027
Figure 16: Global Vascular Stents Market Value Share Analysis, by Material, 2018 and 2027
Figure 17: Global Vascular Stents Market Attractiveness Analysis, by Material, 2019–2027
Figure 18: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cobalt-Chromium Stent, 2017–2027
Figure 19: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Platinum-Chromium Stent, 2017–2027
Figure 20: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Nitinol Stent, 2017–2027
Figure 21: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Stainless Steel Stent, 2017–2027
Figure 22: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Bioresorbable Polymer Stent, 2017–2027
Figure 23: Global Vascular Stents Market Value Share Analysis, by End-user, 2018 and 2027
Figure 24: Global Vascular Stents Market Attractiveness Analysis, by End-user, 2019–2027
Figure 25: Global Vascular Stents Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Hospitals, 2017–2027
Figure 26: Global Vascular Stents Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Cardiac Centers, 2017–2027
Figure 27: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2017–2027
Figure 28: Global Vascular Stents Market Value Share, by Region, 2018 and 2027
Figure 29: Global Vascular Stents Market Attractiveness, by Region, 2019–2027
Figure 30: North America Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 31: North America Vascular Stents Market Value Share (%) Analysis, by Country, 2018 & 2027
Figure 32: North America Vascular Stents Market Attractiveness Analysis, by Country, 2019?2027
Figure 33: North America Vascular Stents Market Value Share Analysis, by Type, 2018 and 2027
Figure 34: North America Vascular Stents Market Attractiveness Analysis, by Type, 2019–2027
Figure 35: North America Vascular Stents Market Value Share Analysis, by Delivery Method, 2018 and 2027
Figure 36: North America Vascular Stents Market Attractiveness Analysis, by Delivery Method, 2019–2027
Figure 37: North America Vascular Stents Market Value Share Analysis, by Material, 2018 and 2027
Figure 38: North America Vascular Stents Market Attractiveness Analysis, by Material, 2019–2027
Figure 39: North America Vascular Stents Market Value Share Analysis, by End-user, 2018 and 2027
Figure 40: North America Vascular Stents Market Attractiveness Analysis, by End-user, 2019–2027
Figure 41: Europe Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 42: Europe Vascular Stents Market Value Share (%) Analysis, by Country/Sub-region, 2018 & 2027
Figure 43: Europe Vascular Stents Market Attractiveness Analysis, by Country/Sub-region, 2019?2027
Figure 44: Europe Vascular Stents Market Value Share Analysis, by Type, 2018 and 2027
Figure 45: Europe Vascular Stents Market Attractiveness Analysis, by Type, 2019–2027
Figure 46: Europe Vascular Stents Market Value Share Analysis, by Delivery Method, 2018 and 2027
Figure 47: Europe Vascular Stents Market Attractiveness Analysis, by Delivery Method, 2019–2027
Figure 48: Europe Vascular Stents Market Value Share Analysis, by Material, 2018 and 2027
Figure 49: Europe Vascular Stents Market Attractiveness Analysis, by Material, 2019–2027
Figure 50: Europe Vascular Stents Market Value Share Analysis, by End-user, 2018 and 2027
Figure 51: Europe Vascular Stents Market Attractiveness Analysis, by End-user, 2019–2027
Figure 52: Asia Pacific Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 53: Asia Pacific Vascular Stents Market Value Share (%) Analysis, by Country/Sub-region, 2018 & 2027
Figure 54: Asia Pacific Vascular Stents Market Attractiveness Analysis, by Country/Sub-region, 2019?2027
Figure 55: Asia Pacific Vascular Stents Market Value Share Analysis, by Type, 2018 and 2027
Figure 56: Asia Pacific Vascular Stents Market Attractiveness Analysis, by Type, 2019–2027
Figure 57: Asia Pacific Vascular Stents Market Value Share Analysis, by Delivery Method, 2018 and 2027
Figure 58: Asia Pacific Vascular Stents Market Attractiveness Analysis, by Delivery Method, 2019–2027
Figure 59: Asia Pacific Vascular Stents Market Value Share Analysis, by Material, 2018 and 2027
Figure 60: Asia Pacific Vascular Stents Market Attractiveness Analysis, by Material, 2019–2027
Figure 61: Asia Pacific Vascular Stents Market Value Share Analysis, by End-user, 2018 and 2027
Figure 62: Asia Pacific Vascular Stents Market Attractiveness Analysis, by End-user, 2019–2027
Figure 63: Latin America Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 64: Latin America Vascular Stents Market Value Share (%) Analysis, by Country/Sub-region, 2018 & 2027
Figure 65: Latin America Vascular Stents Market Attractiveness Analysis, by Country/Sub-region, 2019?2027
Figure 66: Latin America Vascular Stents Market Value Share Analysis, by Type, 2018 and 2027
Figure 67: Latin America Vascular Stents Market Attractiveness Analysis, by Type, 2019–2027
Figure 68: Latin America Vascular Stents Market Value Share Analysis, by Delivery Method, 2018 and 2027
Figure 69: Latin America Vascular Stents Market Attractiveness Analysis, by Delivery Method, 2019–2027
Figure 70: Latin America Vascular Stents Market Value Share Analysis, by Material, 2018 and 2027
Figure 71: Latin America Vascular Stents Market Attractiveness Analysis, by Material, 2019–2027
Figure 72: Latin America Vascular Stents Market Value Share Analysis, by End-user, 2018 and 2027
Figure 73: Latin America Vascular Stents Market Attractiveness Analysis, by End-user, 2019–2027
Figure 74: Middle East & Africa Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 75: Middle East & Africa Vascular Stents Market Value Share (%) Analysis, by Country/Sub-region, 2018 & 2027
Figure 76: Middle East & Africa Vascular Stents Market Attractiveness Analysis, by Country/Sub-region, 2019?2027
Figure 77: Middle East & Africa Vascular Stents Market Value Share Analysis, by Type, 2018 and 2027
Figure 78: Middle East & Africa Vascular Stents Market Attractiveness Analysis, by Type, 2019–2027
Figure 79: Middle East & Africa Vascular Stents Market Value Share Analysis, by Delivery Method, 2018 and 2027
Figure 80: Middle East & Africa Vascular Stents Market Attractiveness Analysis, by Delivery Method, 2019–2027
Figure 81: Middle East & Africa Vascular Stents Market Value Share Analysis, by Material, 2018 and 2027
Figure 82: Middle East & Africa Vascular Stents Market Attractiveness Analysis, by Material, 2019–2027
Figure 83: Middle East & Africa Vascular Stents Market Value Share Analysis, by End-user, 2018 and 2027
Figure 84: Middle East & Africa Vascular Stents Market Attractiveness Analysis, by End-user, 2019–2027
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Vascular Stents Market
